Dr. Pascual's research endeavors have focused mainly on systemic lupus erythematosus and juvenile arthritis. She has received a number of grants, mainly from the National Institutes of Health (NIH), to support her investigations. She has been very productive in her research. Her curriculum vitae lists 53 publications in peer-reviewed medical journals plus 31 chapters and reviews in either books or medical journals. During the last 4 years, she has lectured around the world at a number of prominent meetings. She is also a very nice woman. It was a pleasure to have the opportunity to talk to her for 2½ hours. She is a real credit to Baylor University Medical Center (BUMC).
William Clifford Roberts, MD (hereafter, Roberts): Dr. Pascual Virginia Pascual, MD (hereafter, Pascual): I was born in Madrid, Spain, but grew up in Ceuta, Spain (Figure 2 ), located in the very north of Morocco, 17 kilometers across the ocean from Tarifa, which is in the south of Spain. Ceuta is a Spanish colony. The city has belonged to Spain since the 15th century, and before that it belonged to Portugal. It has never been part of Morocco. Ceuta is 21 square kilometers in size, it is surrounded by ocean, and its climate is mild.
Roberts: What is the area that is owned by Spain called?
Pascual: Today it is an autonomous city. In Spanish it is Ciudad Autónoma. It has its own local government, and Spanish is the official language. Most of the population is Spanish.
Roberts: How large a city was Ceuta when you were living there?
Pascual: Around 65,000 people.
Roberts: What supports the city?
Pascual: It started off as a military fort; strategically, it is very well positioned because it is at the entrance into the Mediterranean Sea (Figure 3 ). Because Spain lost Gibraltar to the United Kingdom-and Gibraltar held a similar position at the opening of the Mediterranean Sea-Spain had a special interest in keeping Ceuta, which is a very crowded port. Military and commerce are strong in Ceuta. As a duty-free port, it attracts many visitors.
Pascual:
In my time, elementary school was for students aged 5 to 10 and bachiller, for students aged 11 to 16. Subsequently, the system has changed, and it is now closer to the American system. Pascual: I started learning English in medical school. We had textbooks that were only in English. Medical English was quite easy to understand. I realized that English was going to be a very important language in my career, so during medical school I went to England during the summers for a month to go to school. I studied English more and more seriously.
Roberts: Was it easy to get into medical school?
Pascual: For me it was easy. The year I started medical school was the year that Spain introduced the "selectivity exam," which everyone had to take to go to university. Before that there was no national test. I took the exam and did well.
Roberts: Do you have any idea how many people applied to your medical school?
Pascual: I don't have those numbers. In Spain, even today, it is much easier to get into medical school than to get into a residency program. The latter is very tough.
Roberts: How many were in your medical school class? You began medical school in 1976?
Pascual: In the Complutense Universidad, there were probably close to 400 per year. The first 2 years of my medical school were done at the San Pablo College: professors from the Complutense University held classes there. The classes contained 70 or 80 students.
Roberts: Were the colleges close together?
Pascual: No, they were a good distance apart.
Roberts: How did you get around in Madrid?
Pascual: I took the bus or the metro.
Roberts: During those first 2 years, how many of the classes actually concerned medicine?
Pascual: Medical school in Spain is 6 years. The first 2 years are the very basic courses, just like in the USA: mathematics, physics, chemistry, biology. In the third year of medical school we had pathology, microbiology, and subjects more related to medicine. I took anatomy and physiology the first year. We had 2 full years of anatomy.
Roberts: Did you enjoy medical school from the beginning? Pascual: Yes. It was pretty much what I was expecting. My favorite subject was pathology. The third year was a highlight, because I loved pathology.
Roberts: Did you find that you had to study more when you entered medical school, or did it seem to just flow?
Pascual: I was used to studying very hard, so it was just a little more but not overwhelming.
Roberts: In your last years of medical school, as you started rotating through internal medicine, pediatrics, surgery, radiology, and other specialties, did you decide fairly quickly what you wanted to go into?
Pascual: No. I always knew I was not going to be a surgeon. That was clear from the beginning.
Roberts: Why is that? Pascual: I was not attracted to surgery. I never thought that I had enough skills to do it well. I was very attracted by pathology. Among the clinical specialties, I preferred pediatrics over internal medicine. My two options were pathology and pediatrics.
Roberts: How did you choose? Pascual: It was chosen for me. As mentioned, the main bottleneck in Spain is the entry into residency. When I finished medical school in 1981, there were 20,000 applicants for 2000 residency positions. We had to take another national exam. I took it and got a pretty good score. At the time I thought I wanted to do pathology in Madrid in a very good hospital. They asked everyone who had passed the test (the first 2000 positions) to come to an auditorium and then the first-place applicant chose the specialty and hospital and then the second person and so on. You had to be there to choose. Pathology was not a very sought-after specialty, so I was convinced I would end up in the hospital and the position I wanted. Then, when I selected my choice, a gentleman said that the pathology positions were taken. I couldn't understand how that could be. The pathology positions had been filled the previous year by servicemen who had reserved residency positions because of their mandatory military obligations. Thus, I chose pediatrics and found a very good opening in a hospital in Madrid.
Roberts: What was the hospital where you did your medical school training in Madrid?
Pascual: It was a very nice Catholic hospital, very traditional with very old buildings, run by the nuns. Pediatrics was one of the highlights. A professor of pediatrics in medical school, who was a great man, was at this hospital. I enjoyed it very much. Pascual: Liver diseases fascinated me. I took care of kids with congenital biliary atresia, and I enjoyed that very much. I wanted to study pediatric gastroenterological diseases. I was also very interested in nutrition. The chief of gastroenterology, Javier Manzanares, also was a superb physician, and he made a big impression on me.
Roberts: What happened after you completed your fourth year of pediatric residency?
Pascual Pascual: I came to Children's Hospital. There were only two attendings in the pediatric gastroenterology program, and they were so overwhelmed that they did not seem to enjoy what they were doing. They had many patients, most of them with complex problems. I found myself involved with two very stressed gastroenterologists. I explained my dissatisfaction to some fellows at Children's, and I was told that I didn't have to stay there. Children's Hospital was not paying my salary; my salary was coming from Spain. The opportunity for basic research was presented to me. I asked myself, "Why should I do research?" Roberts: You had never done any research before?
that I liked. They said once you learn the basics, like Western blots, etc., you would be much less intimidated by science. I thought about it and said they were absolutely right. I had nothing to lose. I was already very impressed with UTSWMC. My fellow colleagues introduced me to a mentor. I ended up in the office of Don Capra, who was a full professor of microbiology, and he had a big lab with 25 people. Capra asked me, "Why do you want to do research? What are you expecting?" I said, "I need some basic science and I will eventually return to my country." He understood that I had had no experience in research. I had been told that Dr. Capra believed that physicians could do good research even without previous experience. He said, "My best experiences in research have been with MDs, and I would be happy to take you."
Roberts: This was in October 1987?
Pascual: Yes.
Roberts: That was a major turning point in your professional career.
Pascual: Absolutely. Don said, "Yes, come, especially if I don't have to pay your salary. What do I have to lose?" A Spanish postdoctoral fellow was finishing his training in June 1988, and Don said I should work with him: "He has done well. You may learn a lot. He is a very smart person." By December 1987, I was completely captivated by what I was doing. I was in the lab from 9:00 am until 11:00 pm every day of the week.
Roberts: What were you doing? Pascual: I was trying to clone genes encoding the variable regions of human autoantibodies. I was very lucky because in 1987, polymerase chain reaction (PCR) had just been discovered, and PCR machines started to be available. My mentor, Don Capra, got one of the first PCR machines at UTSWMC. He basically gave it to me and said, "Make it work." It was easy to work with PCR and so exciting. Very quickly I was able to clone genes in a very efficient manner. I was very fortunate because it gave me confidence that I could do molecular biology. It was something I really enjoyed doing. I never looked back at gastroenterology or anything else until 2 or 3 years later when I realized that I was missing patients. I was so immersed in basic research.
Roberts: You stayed with Don Capra for 10 years? Pascual: Yes ( Figure 5 ).
Roberts: But in 3 years you realized you were missing being with the patients. What happened?
Pascual: In those 3 years I was successful and published quite a good number of articles. Don was a great mentor. He gave me a lot of confidence in myself. By 1992, I had obtained a semifaculty position: research assistant professor, which was pretty quick for somebody who didn't have a PhD or previous basic research experience. After 3 years Don was asking me about my future. "Do you want to be exclusively a basic investigator, or do you want to combine this with being a clinician?" I wanted both, to be a "physician scientist."
To be a clinician in the USA, I had to get accredited and probably do a fellowship. (I had passed the ECFMG test before I came to the USA in 1986.) I thought initially about a fellowship in pediatric gastroenterology, but the laboratory work I was doing with Don involved the immune system and cloning genes, and I liked it very much. I thought if I was going to have a specialty that had something to do with my basic research it was either pathology or rheumatology. I got in touch with the head of the pediatric rheumatology division, Chester Fink, and he accepted me in a fellowship. Dr. Fink liked the idea of having someone already trained in research as a fellow in rheumatology.
Roberts: How long was the fellowship? Pascual: Three years. To promote me quickly to assistant professor and to get my licensing fixed up, I needed some time as a pediatric resident. I was already 35 in 1992; I couldn't waste much time. The chairman of pediatrics, Chuck Ginsburg, made it easy for me. During the 36 months of fellowship, 8 months were spent as a resident in pediatrics at Children's Hospital. I was on call every fourth night. I was an intern for a month, and then the remaining 7 months I was a senior resident. It was good to go through the training here. It was so different from my residency in Spain.
Roberts: In what way? Pascual: Residents in Spain and in many other European countries are on call, staying in the hospital, every fifth or sixth night, but there were always staff attendings in the hospital. When on call in Spain, if I was not confident in managing a patient, I could call a staff physician who would come see a patient with me. At Children's Hospital in Dallas, residents are on their own. A senior resident has a bigger responsibility here than in hospitals in Europe. A staff person can be called at home, but that is different than simply knocking on their door.
The other difference is that Children's was the main pediatric hospital in the whole area. The cases I saw the 8 months of residency were amazing compared with those I saw as a resident in Spain for 4 years. I saw many conditions at Children's that I had never seen in Spain. Madrid is a city of 4 million people, but there are six huge pediatric hospitals, so the unusual conditions are all spread out. In Dallas, they are concentrated at Children's Hospital. When you go to the intensive care unit at Children's in Dallas, it's simply amazing the amount of diversity of pathology one sees. It was a very interesting clinical experience to do 8 months of residency at Children's in Dallas.
Roberts: Were you able to keep your research going during your fellowship in rheumatology?
Pascual: My research definitely slowed down during those months, even though Don was always a very generous mentor. He always gave me technicians to work on my project. I also had students working under me so I could be gone. My research wasn't of the intensity that I had before, but it was still a productive time.
Roberts: You finished your fellowship in pediatric rheumatology? Pascual: Yes. I had two wonderful mentors: Chester Fink, the division head, and Lynn Punaro, both absolutely outstanding clinicians who made me think from the very first day that I had made the right move. I loved getting back to patients, and I love it to this day.
Roberts: You finished your fellowship in 1995. What happened then?
Pascual: I was offered a faculty position: assistant professor of pediatrics and microbiology. I was working with patients and was also keeping my laboratory in the operation of my former mentor, Don Capra. I was happy there. I was able to get some grants, a painful part of research. Then, in 1997, Don Capra decided to move to Oklahoma as the president of the Oklahoma Medical Research Foundation. He asked me to go there with him, but I decided to stay in Dallas. I liked very much the UTSWMC clinical and research environments. However, it started to get a little difficult for me when he left because the microbiology department was not very supportive of me as an investigator. I had to move back to the pediatric department, which did not have any laboratory space. I found myself in an uncomfortable position. I had support from the NIH, but I didn't have the right space to conduct my research.
Roberts: At that time you were head of the pediatric rheumatology division?
Pascual: Yes. Chester Fink had retired. There were only two pediatric rheumatologists for all of northeast Texas, and one of them was me. The two of us took care of a population of over 1500 children with rheumatic diseases. At least 50% of my time was devoted to clinical duties, and then I was trying to continue my research without much support from the medical school.
Roberts: How did it come about that you came to Baylor Dallas?
Pascual: Although I was overwhelmed with clinical work, and although my research was funded by an NIH grant I had acquired, I essentially had no lab. Then Baylor Dallas knocked on my door. Jacques Banchereau had come to Baylor to create a new institute for immunology research. I had collaborated with Jacques since 1992 when he was in France. We had worked together in what I think was one of my most important papers in 1994. In that article (I was first author), we described specific markers that could be used to separate different stages of human mature B cells. We cloned and sequenced the various immunoglobulin genes in all these populations. We showed where the mutations started.
I was delighted that Jacques came to Dallas to lead a new institute for human immunology. When Jacques learned about my situation at UTSWMC, he called me. He said, "We will offer you laboratory space. You can come to this institute and pursue your research here." I thought that was fantastic. Jacques offered me a full lab, whereas UTSWMC was offering me maybe a bench in somebody else's lab. Thus, I took my six people-including postdoctoral fellows (pediatric hematology/oncology, etc.) and technicians-and came to Baylor Dallas. I retained my major appointment as division director at UTSWMC. That was 1998. The joint affiliation worked out very well because Baylor was very supportive. My research blossomed. I was able to publish and get more grants.
Roberts: How did you know Jacques earlier?
Pascual: My mentor, Don Capra, had collaborated with him. He was a consultant also for Jacques' operation in Lyon, France. I met Jacques in 1990 in France at a meeting organized by the Pasteur-Merieux Foundation. Jacques had just published a very important paper in Nature and was presenting his work. I also went there to give a talk. In 1992, we initiated our collaboration. I traveled a few times back and forth to his laboratory to get help and learned how to separate the human B cells from the tonsil. In 1993, Jacques came to the microbiology department at UTSWMC for a 3-to 4-month minisabbatical. We became friends.
Roberts Pascual: BIIR is well recognized around the world as one of the leading institutions in human immunology research. Jacques Banchereau is one of the major experts in human dendritic cell biology. He just published in Nature a major review on dendritic cells. This year's Lasker Prize in Medicine recipient, Dr. Ralph Steinman, spoke recently at the tenth anniversary of the BIIR. We have leading world experts in human molecular biology, like Gerard Zurawski. Karolina Palucka is a fantastic investigator in the field of cancer at BIIR. We have a state-of-the-art microarray and bioinformatics facility led by a young investigator, Damien Chaussabel, who is helping us develop very useful tools to understand human immune-mediated diseases. Our work is very well accepted by our peers.
Roberts: Are you surprised that BIIR has been as successful as it has been when unconnected to a medical school?
Pascual: It is an unusual situation. The energy and enthusiasm of our director, Jacques Banchereau, and the support that BUMC has offered definitely contribute to our success as an independent entity.
Roberts Pascual: I love Asia. Japan is an example (Figure 8 ). I like the Japanese people, their food, and their culture. I was impressed during a short trip to China this year as well. But there are so many exciting places in the world! Roberts: Dr. Pascual, thank you for your openness. It has been a pleasure getting to know you a bit.
Pascual: Thank you. It has been my pleasure.
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